Griffin Asset Management’s Thermo Fisher Scientific TMO Stock Holding History

Griffin Asset Management’s Portfolio TMO Stock Details TMO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q3	–	Sell	-1,209	Closed	-$438K	–	216
2020 Q2	$438K	Hold	1,209	–	–	0.07%	155
2020 Q1	$343K	Buy	1,209 +1	+0.1%	+$315	0.07%	154
2019 Q4	$392K	Buy	1,208 +1	+0.1%	+$303	0.05%	168
2019 Q3	$352K	Buy	1,207 +1	+0.1%	+$286	0.05%	173
2019 Q2	$354K	Buy	1,206 +1	+0.1%	+$275	0.05%	197
2019 Q1	$330K	Hold	1,205	–	–	0.05%	201
2018 Q4	$270K	Buy	1,205 +1	+0.1%	+$235	0.05%	196
2018 Q3	$294K	Buy	1,204 +1	+0.1%	+$230	0.04%	206
2018 Q2	$249K	Buy	1,203 +1	+0.1%	+$212	0.05%	188
2018 Q1	$248K	Buy	1,202 +1	+0.1%	+$210	0.05%	189
2017 Q4	$228K	Buy	1,201 +1	+0.1%	+$192	0.04%	189
2017 Q3	$227K	Hold	1,200	–	–	0.04%	197
2017 Q2	$209K	Buy	+1,200	New	+$202K	0.06%	121
2015 Q2	–	Sell	-4,500	Closed	-$605K	–	103
2015 Q1	$605K	Hold	4,500	–	–	0.18%	76
2014 Q4	$564K	Hold	4,500	–	–	0.15%	80
2014 Q3	$548K	Buy	+4,500	New	+$547K	0.16%	76

Other funds holding TMO

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Griffin Asset Management's TMO Position: Q3 2020 in Review

Griffin Asset Management sold out of Thermo Fisher Scientific (TMO) in Q3 2020, closing a stake of 1,209 shares — an estimated $438K sold.

Griffin Asset Management first reported a position in TMO in Q3 2014 and held it in 16 quarters. The position peaked at $605K in Q1 2015. 1,847 funds tracked by Wall St. Rank hold TMO as of Q3 2020.

Griffin Asset Management reported no remaining Thermo Fisher Scientific position as of Q3 2020 after selling out during the quarter.
Griffin Asset Management sold 1,209 Thermo Fisher Scientific shares in Q3 2020, an estimated $438K.
Griffin Asset Management first reported a position in Thermo Fisher Scientific in Q3 2014 and held it in 16 quarters.
Griffin Asset Management's Thermo Fisher Scientific position peaked at $605K in Q1 2015.
1,847 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q3 2020.

Based on Griffin Asset Management's 13F filing for Q3 2020, filed 12 Nov 2020.